BioNTech SE - ADR vs Spotify Technology — how do they compare? BioNTech SE - ADR trades at $92.23 (market cap $23.31B), while Spotify Technology trades at $501.85 (market cap $105.22B). The key difference: Spotify Technology is far larger — about 4.5× BioNTech SE - ADR's market cap. Which is the better fit depends on your goals.
| BNTX | SPOT | |
|---|---|---|
Market Cap | $23.31B | $105.22B |
Sector | Health | Media |
52-Week High | $119.34 | $738.53 |
52-Week Low | $83.89 | $412.75 |
Enterprise Value | $6.60B | $94.91B |
Trailing returns across standard periods
Latest headlines on both assets
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Spotify Technology S.A. provides music streaming services. The Company offers commercial-free music and ad-supported services to subscribers. Spotify Technology serves clients worldwide.
Read more on SPOT →